Back to search
FDAFDA · Food and drugs·Recall number D-0435-2015

Fexofenadine HCl Tablets, USP, 60 mg, Allergy, Antihistamine, Indoor and Outdoor Allergies, Non-Drowsy, Original Prescription Strength, a) 60 count Bottles, NDC 0378-0781-91, b) 500 count Bottles, NDC 0378-0781-05, Manufactured by: Mylan Pharmaceuticals Inc, Morgantown, WV, 26505, USA.

Published April 15, 2015 · Recall initiated: March 11, 2015

Summary

FDA records drug Class III recall D-0435-2015, published April 15, 2015 and initiated March 11, 2015. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 13,856 Bottles; Lot: Lot #: 3047303, Exp 04/2015. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: out of specification results for a related compound - a degradant of fexofenadine.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mylan Pharmaceuticals Inc.
Distributor
Nationwide
Lot
Lot #: 3047303, Exp 04/2015
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fexofenadine HCl Tablets, USP, 60 mg, Allergy, Antihistamine, Indoor and Outdoor Allergies, Non-Drowsy, Original Prescription Strength, a) 60 count Bottles, NDC 0378-0781-91, b) 500 count Bottles, NDC 0378-0781-05, Manufactured by: Mylan Pharmaceuticals Inc, Morgantown, WV, 26505, USA. recalled?

Yes. FDA published recall D-0435-2015 on April 15, 2015. Reported hazard: Failed Impurities/Degradation Specifications: out of specification results for a related compound - a degradant of fexofenadine.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail